Cargando…
Factors Associated with Human Papillomavirus Vaccination among Women in the United States
BACKGROUND: Human papillomavirus (HPV) infection is the most common sexually transmitted infection (STI) in the United States (US). HPV vaccines have the ability to prevent infection with HPV. The objective of this study was to assess the factors associated with HPV vaccination among women in the US...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6258057/ https://www.ncbi.nlm.nih.gov/pubmed/30498798 http://dx.doi.org/10.20431/2456-0596.0301002 |
_version_ | 1783374436567613440 |
---|---|
author | Sims, Alexis Archie-Booker, Elaine Waldrop, Reinetta T. Claridy, Mechelle Gerbi, Gemechu |
author_facet | Sims, Alexis Archie-Booker, Elaine Waldrop, Reinetta T. Claridy, Mechelle Gerbi, Gemechu |
author_sort | Sims, Alexis |
collection | PubMed |
description | BACKGROUND: Human papillomavirus (HPV) infection is the most common sexually transmitted infection (STI) in the United States (US). HPV vaccines have the ability to prevent infection with HPV. The objective of this study was to assess the factors associated with HPV vaccination among women in the US. METHODS: Data from the 2014 Behavioral Risk Factor Surveillance System were used to assess predictors of HPV vaccination. A multivariable logistic regression analysis was used to estimate adjusted odds ratios (AORs) and 95% confidence intervals (95% CIs). Analyses were conducted using SAS Version 9.4. RESULTS: Factors that decreased the likelihood of receiving HPV vaccination included: being between the ages of 27–50 (AOR: 0.08; 95% CI: 0.06–0.11), having some college education, and residing in the South Black Belt States (AOR: 0.49; 95% CI: 0.31–0.78), Midwest (AOR: 0.63; 95% CI: 0.44–0.90), and the West (AOR: 0.37; 95% CI: 0.15–0.95). Factors that decreased the likelihood of receiving HPV vaccination to completion included: being Non-Hispanic Black (AOR: 0.26; 95% CI: 0.11–0.64), Hispanic (AOR: 0.26; 95% CI: 0.10–0.68), between the ages of 27–50 years (AOR: 0.46; 95% CI: 0.26–0.84), and residing in the Midwest (AOR: 0.36; 95% CI: 0.18–0.73) and South Remainder (non- Black Belt) states (AOR: 0.30; 95% CI: 0.09–0.93). CONCLUSION: Our results suggest that sociodemographic disparities still exist in more recent data underscoring the urgent need for additional efforts to increase HPV vaccination in populations that are least likely to receive the vaccination. |
format | Online Article Text |
id | pubmed-6258057 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
record_format | MEDLINE/PubMed |
spelling | pubmed-62580572018-11-27 Factors Associated with Human Papillomavirus Vaccination among Women in the United States Sims, Alexis Archie-Booker, Elaine Waldrop, Reinetta T. Claridy, Mechelle Gerbi, Gemechu ARC J Public Health Community Med Article BACKGROUND: Human papillomavirus (HPV) infection is the most common sexually transmitted infection (STI) in the United States (US). HPV vaccines have the ability to prevent infection with HPV. The objective of this study was to assess the factors associated with HPV vaccination among women in the US. METHODS: Data from the 2014 Behavioral Risk Factor Surveillance System were used to assess predictors of HPV vaccination. A multivariable logistic regression analysis was used to estimate adjusted odds ratios (AORs) and 95% confidence intervals (95% CIs). Analyses were conducted using SAS Version 9.4. RESULTS: Factors that decreased the likelihood of receiving HPV vaccination included: being between the ages of 27–50 (AOR: 0.08; 95% CI: 0.06–0.11), having some college education, and residing in the South Black Belt States (AOR: 0.49; 95% CI: 0.31–0.78), Midwest (AOR: 0.63; 95% CI: 0.44–0.90), and the West (AOR: 0.37; 95% CI: 0.15–0.95). Factors that decreased the likelihood of receiving HPV vaccination to completion included: being Non-Hispanic Black (AOR: 0.26; 95% CI: 0.11–0.64), Hispanic (AOR: 0.26; 95% CI: 0.10–0.68), between the ages of 27–50 years (AOR: 0.46; 95% CI: 0.26–0.84), and residing in the Midwest (AOR: 0.36; 95% CI: 0.18–0.73) and South Remainder (non- Black Belt) states (AOR: 0.30; 95% CI: 0.09–0.93). CONCLUSION: Our results suggest that sociodemographic disparities still exist in more recent data underscoring the urgent need for additional efforts to increase HPV vaccination in populations that are least likely to receive the vaccination. 2018 /pmc/articles/PMC6258057/ /pubmed/30498798 http://dx.doi.org/10.20431/2456-0596.0301002 Text en http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Article Sims, Alexis Archie-Booker, Elaine Waldrop, Reinetta T. Claridy, Mechelle Gerbi, Gemechu Factors Associated with Human Papillomavirus Vaccination among Women in the United States |
title | Factors Associated with Human Papillomavirus Vaccination among Women in the United States |
title_full | Factors Associated with Human Papillomavirus Vaccination among Women in the United States |
title_fullStr | Factors Associated with Human Papillomavirus Vaccination among Women in the United States |
title_full_unstemmed | Factors Associated with Human Papillomavirus Vaccination among Women in the United States |
title_short | Factors Associated with Human Papillomavirus Vaccination among Women in the United States |
title_sort | factors associated with human papillomavirus vaccination among women in the united states |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6258057/ https://www.ncbi.nlm.nih.gov/pubmed/30498798 http://dx.doi.org/10.20431/2456-0596.0301002 |
work_keys_str_mv | AT simsalexis factorsassociatedwithhumanpapillomavirusvaccinationamongwomenintheunitedstates AT archiebookerelaine factorsassociatedwithhumanpapillomavirusvaccinationamongwomenintheunitedstates AT waldropreinettat factorsassociatedwithhumanpapillomavirusvaccinationamongwomenintheunitedstates AT claridymechelle factorsassociatedwithhumanpapillomavirusvaccinationamongwomenintheunitedstates AT gerbigemechu factorsassociatedwithhumanpapillomavirusvaccinationamongwomenintheunitedstates |